Phil F. Xie
University of Oxford(GB)Ludwig Cancer Research(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, Pancreatic and Hepatic Oncology Research, CAR-T cell therapy research
Most-Cited Works
- → Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma(2023)43 cited
- → Breaking Down Cell-Free DNA Fragmentation: A Markov Model Approach(2023)1 cited
- → Abstract 1247: Comprehensive molecular profiling to predict first-line immunochemotherapy outcomes in inoperable esophageal adenocarcinoma(2022)
- → Abstract LB131: Association between epigenetic heterogeneity of esophageal adenocarcinoma and response to first-line immunochemotherapy in LUD2015-005 Trial(2023)
- → Abstract PR017: A T-cell signature in circulating cell-free DNA at time of diagnosis predicts response to checkpoint inhibition(2024)
- → Abstract CT208: High tumor monocyte content predicts long-term survival for patients with operable oesophageal cancer treated with neoadjuvant immunochemotherapy in the LUD2015-005 trial(2024)
- → Abstract B051: A T-cell signature in circulating cell-free DNA at time of diagnosis predicts response to checkpoint inhibition(2024)
- → Abstract 2489: A cell-free DNA methylation biomarker outperforms irRECIST in predicting treatment outcome(2024)